Career history of Jack Tsai
Former positions of Jack Tsai
| Companies | Position | Start | End |
|---|---|---|---|
| INHIBRX, INC. | Corporate Officer/Principal | 27/10/2021 | 31/08/2022 |
Training of Jack Tsai
| MIT Sloan School of Management | Masters Business Admin |
| Rochester Christian University | Undergraduate Degree |
| Tufts University School of Medicine | Doctorate Degree |
Statistics
International
| United States | 5 |
Operational
| Corporate Officer/Principal | 1 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Inhibrx, Inc.
 Inhibrx, Inc. BiotechnologyHealth Technology Inhibrx, Inc., is a clinical stage biotechnology company, focuses on developing pipeline of novel biologic therapeutic candidates. The firm’s pipeline is focused on oncology, orphan diseases and infectious diseases. It utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. The company was founded by Mark Paul Lappe, Quinn Deveraux and Brendan P. Eckelman in April 2010 and is headquartered La Jolla, CA. | Health Technology |
- Stock Market
- Insiders
- Jack Tsai
- Experience
